Title : Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.

Pub. Date : 2010 Dec

PMID : 21091142






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nilotinib (Tasigna( )) is a more potent BCR-ABL inhibitor than imatinib and was designed to overcome imatinib"s deficiencies. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Nilotinib (Tasigna( )) is a more potent BCR-ABL inhibitor than imatinib and was designed to overcome imatinib"s deficiencies. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens